Cancer Stem Cells: Similarities and Variations in the Theme of Normal Stem Cells

Cancer Stem Cells: Identification and Targets

Volumn , Issue , 2008, Pages 1-26

  Bapat, Sharmila ^a   Collins, Anne ^b,c   Dean, Michael ^d   Nephew, Kenneth ^e   Rasheed, Suraiya ^f  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b YCR Cancer Research Unit   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d NATIONAL CANCER INSTITUTE   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

cancer stem cells (CSCs); CSCs self renewal and differentiation; Normal stem cells similarities and variations

Indexed keywords

EID: 84872367707     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470391594.ch1     Document Type: Chapter

References (132)

1. Beard J. Embryological aspects and etiology of carcinoma. Lancet. 1902; 1:1758-1761.
2. Yamanaka Y, Ralston A, Stephenson RO, Rossant J. Cell and molecular regulation of the mouse blastocyst. Dev Dyn. 2006; 235:2301-2314.
3. Beard J. The action of trypsin upon living cells of the Jensen sarcoma. Brt Med J. 1906; 1:140-141.
4. Costa FF, Le Blanc AK, Brodin BB. Cancer/testis antigens, stem cells and cancer. Stem Cells. 2007; 25:707-711.
5. McCulloch EA, Till JE. Perspectives on the properties of stem cells. Nat Med. 2005; 11:1026-1028.
6. WichaMS, Liu S, Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Res. 2006; 66:1883-1890.
7. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414:105-111.
8. Ralston A, Rossant J. Genetic regulation of stem cell origins in the mouse embryo. Clin Genet. 2005; 68:106-112.
9. Tiedemann H, Asashima M, Grunz H, Knöchel W. Pluripotent cells (stem cells) and their determination and differentiation in early vertebrate embryogenesis. Dev Growth Differ. 2001; 43:469-502.
10. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418:41-49.
11. Tam PP, Loebel DA. Gene function in mouse embryogenesis: get set for gastrulation. Nat Rev Genet. 2007; 8:368-381.
12. Hill MA. Early human development. Clin Obstet Gynecol. 2007; 50:2-9.
13. Mikawa T, Poh AM, Kelly KA, Ishii Y, Reese DE. Induction and patterning of the primitive streak, an organizing center of gastrulation in the amniote. Dev Dyn. 2004; 229:422-432.
14. Kinder SJ, Tsang TE, Quinlan GA, Hadjantonakis AK, Nagy A, Tam PP. The orderly allocation of mesodermal cells to the extraembryonic structures and the anteroposterior axis during gastrulation of the mouse embryo. Development. 1999; 126:4691-4701.
15. Lu CC, Brennan J, Robertson EJ. From fertilization to gastrulation: axis formation in the mouse embryo. Curr Opin Genet Dev. 2001; 11:384-392.
16. Kinder SJ, Loebel DA, Tam PP. Allocation and early differentiation of cardiovascular progenitors in the mouse embryo. Trends Cardiovasc Med. 2001; 11:177-184.
17. Baron MH. Early patterning of the mouse embryo: implications for hematopoietic commitment and differentiation. Exp. Hematol. 2005; 33:1015-1020.
18. Yoshimizu T, Obinata M, Matsui Y. Stage-specific tissue and cell interactions play key roles in mouse germ cell specification. Development. 2001; 128:481-490.
19. Belaoussoff M, Farrington SM, Baron MH. Hematopoietic induction and respecification of A-P identity by visceral endoderm signaling in the mouse embryo. Development. 1998; 125:5009-5018.
20. Brennan J, Lu CC, Norris DP, Rodriguez TA, Beddington RS, Robertson EJ. Nodal signalling in the epiblast patterns the early mouse embryo. Nature. 2001; 411:965-969.
21. Domen J, Weissman IL. Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate. Mol Med Today. 1999; 5:201-208.
22. Moore KA, Lemischka IR. Stem cells and their niches. Science. 2006; 311:1880-1885.
23. Fuchs E, Segre JA. Stem cells: a new lease on life. Cell. 2000; 100:143-155.
24. McCulloch EA, Siminovitch L, Till JE. Spleen-colony formation in anemic mice of genotype WW. Science. 1964; 144:844-846.
25. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994; 367:645-648.
26. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell. 2001; 105:829-841.
27. Slack JM. Stem cells in epithelial tissues. Science. 2000; 287:1431-1433.
28. Raff M. Adult stem cell plasticity: fact or artifact? Annu Rev Cell Dev Biol. 2003; 19:1-22.
29. Braun KM, Watt FM. Epidermal label-retaining cells: background and recent applications. J Invest Dermatol Symp Proc. 2004; 9:196-201.
30. Bapat SA. Evolution of cancer stem cells. Semin Cancer Biol. 2007; 17:204-213.
31. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature. 2006; 441:1068-1074.
32. Lotem J, Sachs L. Epigenetics and the plasticity of differentiation in normal and cancer stem cells. Oncogene. 2006; 25:7663-7672.
33. Mintz B, Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A. 1975; 72:3585-3589.
34. Brinster RL. Participation of teratocarcinoma cells in mouse embryo development. Cancer Res. 1976; 36:3412-3414.
35. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100:3983-3988.
36. Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A. 2003; 100:15178-15183.
37. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004; 23:7274-7282.
38. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif. 2003; 1:59-72.
39. Hirschmann-Jax C, Foster AE,Wulf GG, et al. A distinct side population of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A. 2004; 101:14228-14233.
40. Setoguchi T, Taga T, Kondo T. Cancer stem cells persist in many cancer cell lines. Cell Cycle. 2004; 3: 414-415.
41. Knudson AG Jr, Strong LC, Anderson DE. Heredity and cancer in man. Prog Med Genet. 1973; 9:113-158.
42. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004; 432:324-331.
43. Okita K, Ichisaka T, Yamanaka S. Nature. 2007; 448:313-317.
44. Wernig M, Meissner A, Foreman R, et al. in vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007; 448:318-324.
45. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126:663-676.
46. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science. 2004; 306:1568-1571.
47. Makino, S. Further evidence favoring the concept of the stem cell in ascites tumors of rats. Ann N Y Acad Sci. 1956; 63:818-830.
48. Kleinsmith LJ, Pierce GB. Multipotentiality of single embryonal carcinoma cells. Cancer Res. 1964; 24:1544-1551.
49. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A. 1992; 89:2804-2808.
50. Spangrude GJ, Aihara Y, Weissman IL, Klein J. The stem cell antigens Sca-1 and Sca-2 subdivide thymic and peripheral T lymphocytes into unique subsets. J Immunol. 1988; 141:3697-3707.
51. Civin CI, Gore SD. Antigenic analysis of hematopoiesis: a review. J Hematother. 1993; 2:137-144.
52. Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood. 1995; 85:2654-2670.
53. MatsuiW, Huff CA,Wang Q, et al. Characterization of clonogenic multiple myeloma cells. Blood. 2004; 103:2332-2336.
54. Hosen N, Park CY, Tatsumi N, et al. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia. Proc Natl Acad Sci U S A. 2007; 104:11008-11013.
55. Smalley M, Ashworth A. Stem cells and breast cancer: a field in transit. Nat Rev Cancer. 2003; 3:832-844.
56. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumor initiating cells. Nature. 2004; 432:396-401.
57. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997; 3:730-737.
58. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005; 65:10946-10951.
59. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005; 121:823-835.
60. Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H. Characterization of CD133C hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun. 2006; 351:820-824.
61. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007; 67:1030-1037.
62. Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007; 104:10158-10163.
63. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature. 2007; 445:106-110.
64. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007; 445:111-115.
65. Ma S, Chan KW, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology. 2007; 132:2542-2556.
66. Hill RP. Identifying cancer stem cells in solid tumors: case not proven. Cancer Res. 2006; 66:1891-1895.
67. Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 2005; 65:3025-3029.
68. Nowell PC. The clonal evolution of tumor cell populations. Science. 1976; 194:23-28.
69. Kruh GD. Introduction to resistance to anticancer agents. Oncogene. 2003; 22:7262-7264.
70. Yen TH, Wright TA. The gastrointestinal tract stem cell niche. Stem Cell Rev. 2006; 2:203-212.
71. Miyata T. Asymmetric cell division during brain morphogenesis. Prog Mol Subcell Biol. 2007; 45:121-142.
72. ZhongW. Themammalian Golgi regulates numb signaling in asymmetric cell division by releasing ACBD3 during mitosis. Cell. 2007; 129:163-178.
73. Shinin V, Gayraud-Morel B, Gomès D, Tajbakhsh S. Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells. Nat Cell Biol. 2006; 8:677-687.
74. Nikolaou S, Gasser RB. Extending from PARs in Caenorhabditis elegans to homologues in Haemonchus contortus and other parasitic nematodes. Parasitology. 2007; 134:461-482.
75. Beckmann J, Scheitza S, Wernet P, Fischer JC, Giebel B. Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins. Blood. 2007; 109:5494-5501.
76. Rebollo E, Sampaio P, Januschke J, Llamazares S, Varmark H, González C. Functionally unequal centrosomes drive spindle orientation in asymmetrically dividing Drosophila neural stem cells. Dev Cell. 2007; 12:467-474.
77. Yamashita YM, Mahowald AP, Perlin JR, Fuller MT. Asymmetric inheritance of mother versus daughter centrosome in stem cell division. Science. 2007; 315:518-521.
78. Kuang S, Kuroda K, Le Grand F, Rudnicki MA. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell. 2007; 129:999-1010.
79. Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 2006; 66:4553-4557.
80. Clarke MF, Fuller M. Stem cells and cancer: two faces of Eve. Cell. 2006; 124:1111-1115.
81. Caussinus E, Hirth F. Asymmetric stem cell division in development and cancer. Prog Mol Subcell Biol. 2007; 45:205-225.
82. Hochedlinger K, Yamada Y, Beard C, Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell. 2005; 121:465-477.
83. Knudson AG. Antioncogenes and human cancer. Proc Natl Acad Sci U S A. 1993; 90:10914-10921.
84. Gostjeva EV, Thilly WG. Stem cell stages and the origins of colon cancer: a multidisciplinary perspective. Stem Cell Rev. 2005;1:243-251.
85. Campbell PA, Perez-Iratxeta C, Andrade-Navarro MA, Rudnicki MA. Oct4 targets regulatory nodes to modulate stem cell function. PLoS ONE. 2007; 2:e553.
86. Boyer LA, Lee TI, Cole MF, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005; 122:1-10.
87. Loh YH, Wu Q, Chew JL, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet. 2006; 38:431-440.
88. Rodda DJ, Chew JL, Lim LH, et al. Transcriptional regulation of nanog by Oct4 and Sox2. J Biol Chem. 2005; 280:24731-24737.
89. Constantinescu S. Stemness, fusion and renewal of hematopoietic and embryonic stem cells. J Cell Mol Med. 2003; 7:103-112.
90. Ying QL, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with Stat3. Cell. 2003; 115:281-292.
91. Masui S, Nakatake Y, Toyooka Y, et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.Nat Cell Biol. 2007; 9:625-635.
92. Fuhrmann G, Chung AC, Jackson KJ, et al. Mouse germline restriction of Oct4 expression by germ cell nuclear factor. Dev Cell. 2001; 1:377-387.
93. Barnea E, Bergman Y. Synergy of SF1 and RAR in activation of Oct-3/4 promoter. J Biol Chem. 2000; 275:6608-6619.
94. Okumura-Nakanishi S, Saito M, Niwa H, Ishikawa F. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J Biol Chem. 2005; 280:5307-5317.
95. Gu P, LeMenuet D, Chung AC, Mancini M, Wheeler DA, Cooney AJ. Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation. Mol Cell Biol. 2005; 25(19):8507-8519.
96. Pietersen AM, van Lohuizen M. Stem cell regulation by polycomb repressors: postponing commitment. Curr Opin Cell Biol. 2008; 20:201-207.
97. Lee TI, Jenner RG, Boyer LA, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006; 125:301-313.
98. Azuara V, Perry P, Sauer S, et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol. 2006; 8:532-538.
99. Johnson BV, Rathjen J, Rathjen PD. Transcriptional control of pluripotency: decisions in early development. Curr Opin Genet Dev. 2006; 16:447-454.
100. Ohm JE, McGarvey KM, Yu X, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet. 2007; 39:237-242.
101. Ho AD,WagnerW. The beauty of asymmetry: asymmetric divisions and self-renewal in the haematopoietic system. Curr Opin Hematol. 2007; 14:330-336.
102. Watt FM, Hogan BL. Out of Eden: stem cells and their niches. Science. 2000; 287:1427-1430.
103. Scadden DT. The stem-cell niche as an entity of action. Nature. 2006; 441:1075-1079.
104. Ohyama, M, Terunuma A, Tock CL, et al. Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest. 2006; 116:249-260.
105. Bach SP, Renehan AG, Potten CS. Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis. 2000; 21:469-476.
106. Ganss R. Tumor stroma fosters neovascularization by recruitment of progenitor cells into the tumor bed. J Cell Mol Med. 2006; 10:857-865.
107. Giangreco A, Groot KR, Janes SM. Lung cancer and lung stem cells: strange bedfellows? Am J Respir Crit Care Med. 2007; 175:547-553.
108. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell. 2003; 4:181-189.
109. Minna JD, Kurie JM, Jacks T. A big step in the study of small cell lung cancer. Cancer Cell. 2003; 4:163-166.
110. Reynolds SD, Giangreco A, Power JH, Stripp BR. Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol. 2000; 156:269-278.
111. Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol. 2004; 164:577-588.
112. Schoch KG, Lori A, Burns KA, Eldred T, Olsen JC, Randell SH. A subset of mouse tracheal epithelial basal cells generates large colonies in vitro. Am J Physiol Lung Cell Mol Physiol. 2004; 286:631-642.
113. Johnson L, Mercer K, Greenbaum D, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature. 2001; 410:1111-1116.
114. Stevens TP, McBride JT, Peake JL, Pinkerton KE, Stripp BR. Cell proliferation contributes to PNEC hyperplasia after acute airway injury. Am J Physiol. 1997; 272:486-493.
115. Giangreco A, Reynolds SD, Stripp BR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol. 2002; 161:173-182.
116. Walkley CR, Olsen GH, Dworkin S, et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor γ deficiency. Cell. 2007; 129:1097-1110.
117. Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell. 2007; 129:1081-1095.
118. Nichols J, Chambers I, Taga T, Smith A. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development. 2001; 128:2333-2339.
119. Batlle E HJ, Beghtel H, van den Born MM, et al. β-Catenin and TCF mediate stem cell positioning in the intestinal epitheleum by controlling the expression of EphB/ephrinB. Cell. 2002; 111:251-263.
120. Boiani M, Scholer H. Regulatory networks in embryo-derived pluripotent stem cells. Nat RevMol Cell Biol. 2005; 6:872-884.
121. Chickarmane V, Troein C, Nuber UA, Sauro HM, Peterson C. Transcriptional dynamics of the embryonic stem cell switch. PLoS Comput Biol. 2006; 2:1080-1092.
122. Burdon T, Smith A, Savatier P. Signalling, cell cycle, and pluripotency in embryonic stem cells. Trends Cell Biol. 2002; 12:432-438.
123. Doucas H, Garcea G, Neal CP,Manson MM, Berry DP. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer. 2005; 41:365-379.
124. Kolligs FT, Bommer G, Goke B. Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion. 2002; 66:131-144.
125. Rask K, Nilsson A, Brannstrom M, et al. Wnt-signalling pathway in ovarian epithelial tumors: increased expression of beta-catenin and GSK3beta. Br J Cancer 2003; 89:1298-1304.
126. Tickle, C. Patterning systems-from one end of the limb to the other. Dev Cell. 2003; 4:449-458.
127. Katano, M. Hedgehog signaling pathway as a therapeutic target in breast cancer. Cancer Lett. 2005; 227:99-104.
128. Sanchez P, Clement V, Ruiz i Altaba A. Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer. Cancer Res. 2005; 65:2990-2992.
129. Hopfer O, Zwahlen D, Fey MF, Aebi S. The Notch pathway in ovarian carcinomas and adenomas. Br J Cancer. 2005; 93:709-718.
130. Wilson A, Radtke F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett. 2006; 580:2860-2868.
131. Duncan AW, Rattis FM, DiMascio LN, et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol. 2005; 6:314-322.
132. Ross J, Li L. Recent advances in understanding extrinsic control of hematopoietic stem cell fate. Curr Opin Hematol. 2006; 13:237-242.